Moreover, oral gavage of 10 mg/kg of formononetin for 31 d significantly inhibited tumor growth in BALB/c mouse model inoculated with HeLa cells and reduced the expression of HIF-1α and VEGF in tumor tissues without severe side effects [104]. This evidence concerns the gene VEGFA and neoplasm.